A SoundCloud podcast episode titled 'Ethics of Kalshi's Drug Betting Markets' features Jonathon Kimmelman, PhD, discussing the ethical dimensions of Kalshi's markets related to pharmaceutical outcomes. The episode is hosted on Managed Care Cast. No transcript or specific claims from the discussion are available in the provided body.

Academic bioethics scrutiny of Kalshi's drug-related contracts signals potential reputational and regulatory risk if ethical concerns migrate into formal policy or CFTC comment letters.